8 December 2015 - Vonvendi is the first FDA approved recombinant von Willebrand factor, and is approved for the on-demand (as needed) treatment and control of bleeding episodes in adults diagnosed with von Willebrand disease.

For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm476065.htm